Evozyne
Business Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2430 N Halsted St, Chicago, Illinois, 60...Phone Number
(872) 757-4050Website
www.evozyne.comRevenue
$14.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Evozyne
Evozyne specializes in designing novel therapeutic proteins using generative AI to address the challenges of immune-mediated diseases. Their AI-native platform, EvoGen, optimizes protein sequences for enhanced potency, stability, specificity, and immunogenicity. The company operates EvoLab, a high-throughput facility that synthesizes and tests thousands of protein candidates, generating proprietary data for their immunology pipeline. Evozyne aims to create scalable immune therapies that can effectively treat patients who do not respond to existing therapies.Explore more
Evozyne Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Evozyne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Evozyne has new funding data
Check out if Evozyne is spiking on competitors!
Check if Evozyne has recently received funding, and reach out quickly before it becomes old news!
Click to see if Evozyne had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Evozyne recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Evozyne
Product Launch: Get notified when Evozyne launches new products
Website visits: Recent activity has been detected on your website
Evozyne, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Evozyne
Find more new buyers
Compare Similar Companies to Evozyne
Compare insights from companies similar to Evozyne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Evozyne is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Evozyne is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Evozyne.
Evozyne financials insights
Gather financial insights about Evozyne, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$81M
Evozyne Tech Stack
A closer look at the technologies used by Evozyne
See more technologies
Most Recent Scoops
Award
Award, Employee Engagement, Compensation & Benefits, Employee Relations, Company Culture & Policy, HR Operations
Open Position
Event
Events
Event
Events
New Hire
Executive Move
Executive Moves, New Hire
Evozyne News & Media
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
CHICAGO--(BUSINESS WIRE)--Chicago AI-powered biotech Evozyne closed $81 million in Series B funding led by OrbiMed and Fidelity, with participation from NVIDIA's NVentures.Veteran Technology Executive Mike Gamson Named Evozyne CEO
Gamson to set commercial direction, strengthen foundation for growth CHICAGO, Jan. 9, 2023 /PRNewswire/ -- Evozyne, a fast-growing biology engineering company, today welcomed Mike Gamson as its new CEO. At Evozyne, Gamson will lead the company into its next phase, aligning its scientific...Evozyne Hires Chief Operating Officer to Scale Scientific Operations for Growth
Zach Serber, PhD, joins the Chicago-based biology engineering company to advance scientific and technical operations CHICAGO, Oct. 18, 2022 /PRNewswire/ -- Evozyne named Zach Serber as its chief operating officer, a newly created position charged with directing scientific operations for...Evozyne Announces Multi-Target Research Collaboration and License Agreement with Takeda to Develop Next-Generation Gene Therapies
– Expansion builds on initial strategic collaboration and license agreement – CHICAGO, April 5, 2022 /PRNewswire/ -- Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Biosciences, announced today that it has entered into a...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Evozyne
Sign Up For FreeTo access detailed company insights
Evozyne specializes in designing novel therapeutic proteins using generative AI to address the challenges of immune-mediated diseases. Their AI-native platform, EvoGen, optimizes protein sequences for enhanced potency, stability, specificity, and immunogenicity. The company operates EvoLab, a high-throughput facility that synthesizes and tests thou... Read More
